China Pharma Holdings CPHI
NYSE CPHI
$0.67 -0.05 (-6.91%)
As of: Sep 29, 2026 · 3:57 PM EDT

China Pharma Holdings (CPHI) Gross Margin (2010 - 2026)

Updated

China Pharma Holdings (CPHI) posted Gross Margin of 8.81% for Q2 2026, up 17.29 percentage points from -8.48% a year earlier but down 20.21 percentage points from the prior quarter.

Analysis

China Pharma Holdings (CPHI) Gross Margin (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Gross Margin at China Pharma Holdings was 11.76%, up 32.30 percentage points year-over-year; for FY2025, it was -3.18%, up 40.66 percentage points from FY2024.

  • Annual Gross Margin shows a five-year change of -21.16 percentage points (FY2020 to FY2025).
  • In prior years, China Pharma Holdings' Gross Margin was -43.84% in FY2024 (-39.83 pp), -4.01% in FY2023 (+2.09 pp), -6.09% in FY2022 (-9.72 pp) and 3.62% in FY2021 (-14.35 pp).
  • Quarterly Gross Margin has run from a low of -109.78% in Q2 2024 to a high of 29.03% in Q1 2026 over five years.
  • On a year-over-year basis, Gross Margin has increased in each of the last six quarters, with an average year-over-year change of +23.73 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Gross Margin in the past five years was Q2 2025, with a gain of 101.30 percentage points; the weakest was Q2 2024, with a drop of 96.42 percentage points.
  • According to Business Quant data, Gross Margin for the three prior quarters was 29.03% (Q1 2026), 12.30% (Q4 2025) and -7.89% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 68.19%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 74.74%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 73.54%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 78.02%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 83.60%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 72.04%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 79.76%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 85.33%
10 China Pharma Holdings 29.58 Mn 28.46 Mn 83,566.00 8.81%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.81%
Mar 31, 2026 29.03%
Dec 31, 2025 12.30%
Sep 30, 2025 -7.89%
Jun 30, 2025 -8.48%
Mar 31, 2025 -11.97%
Dec 31, 2024 -14.16%
Sep 30, 2024 -47.23%
Jun 30, 2024 -109.78%
Mar 31, 2024 -21.17%
Dec 31, 2023 -3.68%
Sep 30, 2023 -12.93%
Jun 30, 2023 -13.36%
Mar 31, 2023 9.08%
Dec 31, 2022 1.46%
Sep 30, 2022 -7.01%
Jun 30, 2022 -14.22%
Mar 31, 2022 -10.56%
Dec 31, 2021 10.45%
Sep 30, 2021 -14.98%
API Access

China Pharma Holdings Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=CPHI&period=max&api_key=YOUR_API_KEY